Funds holding Kailera Therapeutics Inc
ISIN US4829311020 · United States
- Fund holders
- 116
- Of which ETFs
- 13 103 other funds
- Value held
- 336.9M $
- Share of capital
- 12.5 % of 129.6M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD RUSSELL 2000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 989 | 22.7K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 884 | 19.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 829 | 18.3K $ | 0.10 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 651 | 14.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 624 | 13.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 597 | 13.7K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 594 | 10.1K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 328 | 7.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 248 | 5.5K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 190 | 4.2K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 124 | 2.7K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 114 | 2.5K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 104 | 2.3K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 68 | 1.5K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 39 | 660.7 $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 13 | 286.4 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Roundhill GLP-1 & Weight Loss ETF Roundhill ETF Trust | 6.21 % | as of Jun 30, 2026 ↗ |
| Amplify Weight Loss Drug & Treatment ETF Amplify ETF Trust | 2.46 % | as of Jun 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 0.76 % | as of Jun 30, 2026 ↗ |
| Lazard US Small Cap Equity Select Portfolio LAZARD FUNDS INC | 0.69 % | as of Jun 30, 2026 ↗ |
| Columbia Small Cap Growth Fund COLUMBIA FUNDS SERIES TRUST I | 0.41 % | as of May 31, 2026 ↗ |
| HARTFORD HEALTHCARE HLS FUND HARTFORD SERIES FUND INC | 0.38 % | as of Jun 30, 2026 ↗ |
| Columbia Variable Portfolio - Small Company Growth Fund COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.37 % | as of Jun 30, 2026 ↗ |
| Health Sciences Portfolio PACIFIC SELECT FUND | 0.32 % | as of Jun 30, 2026 ↗ |
| THE HARTFORD HEALTHCARE FUND HARTFORD MUTUAL FUNDS, INC | 0.29 % | as of Jul 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 0.29 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 116 | +105 | 16,247,974 | +327.2 % |
| 2026Q2 | 11 | 3,803,741 |
Declared shareholders of Kailera Therapeutics Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 8.90 % | 11,511,853 | as of Jun 30, 2026 · SCHEDULE 13G |
| RTW Investments, LP and 1 other | 8.30 % | 10,776,820 | as of Jun 30, 2026 · SCHEDULE 13G |
| CPP Investment Board Private Holdings (4) Inc. and 1 other | 5.60 % | 7,304,688 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Kailera Therapeutics Inc". https://titelia.com/en/stocks/kailera-therapeutics-inc-US4829311020